Filter...

AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesTechnology, Industry, AgricultureHealth Care

Select a category...

Prothrombin TimeProthrombinPartial Thromboplastin TimeBlood Coagulation TestsThromboplastinBlood Coagulation DisordersBlood CoagulationInternational Normalized RatioThrombin TimeHypoprothrombinemiasAnticoagulantsBlood Coagulation FactorsVitamin K DeficiencyDisseminated Intravascular CoagulationHemostasisWarfarinVitamin KFactor VFactor XaFactor VIIFactor XFibrinogenThrombinAntithrombinsHemorrhagic DisordersHeparinAntithrombin IIIPlatelet CountThrombelastographyBleeding TimePlasmaHemorrhageLupus Coagulation InhibitorCoagulantsProtein CFreeze Drying4-HydroxycoumarinsThrombophiliaFibrinolysisThrombosisFactor IXFactor VIIIFibrin Fibrinogen Degradation ProductsFactor VaAcenocoumarolThromboembolismFibrinopeptide AFactor XIPoint-of-Care SystemsHirudinsPipecolic AcidsHemophilia AFactor VIIaCalibrationBilirubinCefotetanFactor X DeficiencyDrug MonitoringCoumarinsHemostasis, SurgicalProtein SVitamin K 1Fibrinolytic AgentsFibrinPlatelet AggregationBlood Cell CountFactor XII DeficiencyLiver Function TestsChromogenic CompoundsKaolin1-Carboxyglutamic AcidIndicators and ReagentsFactor XI DeficiencyPostoperative HemorrhageAdministration, OralHirudin TherapyHemophilia BHematologic TestsVenous ThrombosisFat SubstitutesMoxalactamFactor VII DeficiencyBlood Specimen CollectionBlood PlateletsActivated Protein C ResistanceCarotid Artery ThrombosisLiver DiseasesThrombophlebitisFactor XIIBlood Coagulation Disorders, InheritedPeptide FragmentsDicumarolHemostatic TechniquesLiver Failure, AcuteLiver CirrhosisTime FactorsHeparin AntagonistsProspective StudiesHemodilutionRabbits

Partial thromboplastin timesAPTTCoagulationFibrinogenLactate dehydrogenasePlasmaClotAbnormalInternationalVivoGeneBleedingDisorderMaximum amplitudeResultsMeasurementsBloodLaboratoryMortalityHospitalIncludePatientsPainHumanManagementSecondsIncreaseMeasureFemaleGreaterPatientChange

Partial thromboplastin times4

• Prothrombin time and partial thromboplastin times are normal. (hawaii.edu)
• Blood tests revealed hepatocellular leakage and cholestasis, hyperlactatemia, thrombocytopenia, and prolonged prothrombin and activated partial thromboplastin times. (cabi.org)
• However, DAH was not associated with prolonged prothrombin or partial thromboplastin times or decreased platelet counts compared with patients without DAH. (nih.gov)
• ABSTRACT Traditionally known as a haemostatic agent, alum shows a paradoxical effect of increased prothrombin and partial thromboplastin times. (who.int)

APTT4

• Activated partial thromboplastin time (aPTT) and prothrombin time (PT) are clinical tests commonly used to screen for coagulation-factor deficiencies. (hw.ac.uk)
• The activated partial thromboplastin time test or (APTT) is best for this. (medicalhealthtests.com)
• Background: Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the tests used in the investigation and monitoring of hemostatic disorders. (bvsalud.org)
• Objective: To determine the effect of varying storage times and temperatures on plasma PT and APTT. (bvsalud.org)

Coagulation2

• This page describes protocols used for hematology parameters (complete blood count with white cell differentials, reticulocyte and red blood cell indices, platelet count and indices), and coagulation parameters (fibrinogen, prothrombin time, partial thromboplastin time). (jax.org)
• Because all coagulation factors are made in the liver (by hepatocytes and hepatic sinusoidal endothelial cells), both the prothrombin time (PT) and partial thromboplastin time (PTT) are prolonged in severe liver disorders. (merckmanuals.com)

Fibrinogen1

• Pertinent laboratory results on ICU admission included leukocytosis, thrombocytopenia, an elevated prothrombin time and partial thromboplastin time, and elevated levels of fibrinogen and D-dimer. (medscape.com)

Lactate dehydrogenase1

• The presence of CVD, chronic kidney disease, prolonged prothrombin time and elevated lactate dehydrogenase (LDH) were associated with mortality. (who.int)

Plasma2

• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. (medscape.com)
• L'agrégation plaquettaire induite par le collagène dans des échantillons de plasma riche en plaquettes de 14 lapins sains a été mesurée par turbidimétrie en utilisant un agrégomètre, avant et une heure après une injection intra- veineuse d'alun. (who.int)

Clot3

• Critically ill dogs had significantly increased maximum amplitude, α angle, and global clot strength and significantly decreased clot formation time. (avma.org)
• This is a blood test to measure the kind of time blood takes to clot. (medicalhealthtests.com)
• Twelve factors of clotting are needed for the blood to coagulate.The activated partial thromboplastin time level test is important because it is necessary to know how long your blood needs to clot. (medicalhealthtests.com)

Abnormal2

• Abnormal assays for factors II and VII in patients with unexplained bleeding and a normal PT, partial thromboplastin time, or INR, as determined by hospital or commercial laboratory tests. (cdc.gov)
• Forty-two percent of patients had abnormal prothrombin time and international normalized ratio. (who.int)

International2

• Over time, his prothrombin time (PT)4 international normalized ratio (INR) values were stable and checked regularly at an anticoagulation clinic. (aacc.org)
• Prolonged prothrombin time (PT) and international normalized ratio (INR) (24 to 72 hours after exposure) persisting for weeks to months, as determined by hospital laboratory tests. (cdc.gov)

Vivo3

• The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. (medscape.com)
• This study investigated the in vivo effect of alum on platelet aggregation and bleeding time in rabbits. (who.int)
• contradiction in the mechanism of action of alum, we evaluated the in vivo effect of Alum (aluminium potassium sulfate) is a alum in terms of collagen-induced platelet food additive and traditional remedy used to aggregation and bleeding time. (who.int)

Gene4

• Atasay B, Arsan S, Gunlemez A, Kemahli S, Akar N. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center. (medscape.com)
• Prevalence of factor V Leiden and prothrombin G20210A gene mutation. (medscape.com)
• The prothrombin gene and its liver-specific expression. (medscape.com)
• Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. (nih.gov)

Bleeding3

• Activated partial thromboplastin time range is generally used to check if the person has bleeding problems. (medicalhealthtests.com)
• This test is done with partial thromboplastin time test to check if the person has bleeding problems due to clotting factors. (medicalhealthtests.com)
• Bleeding time from an ear puncture in 8 rabbits was also significantly prolonged after intravenous alum injection. (who.int)

Disorder1

• Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin. (medscape.com)

Maximum amplitude1

• Compared with nonsedated cats, cats that required sedation had a significantly shorter clotting time and greater α angle, whereas reaction time and maximum amplitude were not significantly different. (avma.org)

Results1

• The time and storage temperature have been shown to affect the results of these tests. (bvsalud.org)

Measurements1

• Severity of illness scores and platelet activation measurements were compared with survival time and duration and cost of hospitalization. (avma.org)

Blood3

• Most of the time, blood in the stool is not caused by a serious medical condition but the only way to be certain is to see a doctor to determine the cause. (emedicinehealth.com)
• The activated partial thromboplastin time level test can be done to check if substances known as inhibitors are affecting the blood clotting. (medicalhealthtests.com)
• Prothrombin time or PT is another blood clotting test that measures clotting factors. (medicalhealthtests.com)

Laboratory1

• A clinically compatible case in which a high index of suspicion (credible threat or patient history regarding location and time) exists for a long-acting anticoagulant exposure, or an epidemiologic link exists between this case and a laboratory-confirmed case. (cdc.gov)

Mortality1

• Mortality from COVID-19 was associated with having CVD, chronic kidney disease, elevated LDH and prolonged prothrombin time. (who.int)

Hospital1

• At that time in the Philippines, cases had risen a Department of Internal Medicine, Baguio General Hospital and Medical Center, Baguio City, Philippines. (who.int)

Include1

• These include PT (prothrombin time) and PTT (partial thromboplastin time). (stanfordchildrens.org)

Patients2

• Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. (medscape.com)
• Ces résultats semblent indiquer que l'utilisation de l'alun en tant qu'antiplaquettaire oral pourrait faire l'objet d'études complémentaires, en tenant compte des effets secondaires éventuels notamment chez les patients dont la fonction rénale est altérée. (who.int)

Pain1

• The preoperative regimen should be documented and detailed instructions to the patient should be given, specifically to avoid cessation of opioids to prevent immediate postoperative acute withdrawal, happening at the time of acute increase in pain. (renalandurologynews.com)

Human1

• Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. (medscape.com)

Management1

• Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. (medscape.com)

Seconds1

• Capillary refill time 2 seconds. (hawaii.edu)

Increase1

• Lorenzo's et al have illustrated that CRP can increase the risk of death 11.7 times after CABG [9] . (researchsquare.com)

Measure1

• To measure the changes in rates over time, we calculated annual percentage change (APC). (cdc.gov)

Female1

• Harel R, Shani D, Donohoe K. A case of congenital prothrombin deficiency and idiopathic thrombocytopenic purpura in a pregnant female. (medscape.com)

Greater1

• The hemodynamic stabilization seemed to have a greater priority at the time. (hawaii.edu)

Patient1

• The patient did a lot of heavy lifting-upwards of 100 pounds at a time. (jabfm.org)

Change1

• You can change these settings at any time, but that may impair functionality on our websites. (clsi.org)